Your browser is no longer supported. Please, upgrade your browser.
Settings
BAX Baxter International Inc. daily Stock Chart
BAX [NYSE]
Baxter International Inc.
IndexS&P 500 P/E5.57 EPS (ttm)9.00 Insider Own10.11% Shs Outstand540.53M Perf Week2.25%
Market Cap27.06B Forward P/E20.44 EPS next Y2.45 Insider Trans-0.02% Shs Float540.04M Perf Month8.78%
Income4.97B PEG0.40 EPS next Q0.51 Inst Own85.60% Short Float1.62% Perf Quarter6.87%
Sales10.16B P/S2.66 EPS this Y10.70% Inst Trans-0.89% Short Ratio2.71 Perf Half Y4.93%
Book/sh15.95 P/B3.14 EPS next Y13.12% ROA- Target Price52.88 Perf Year32.09%
Cash/sh- P/C- EPS next 5Y14.03% ROE- 52W Range37.26 - 50.20 Perf YTD12.90%
Dividend0.52 P/FCF- EPS past 5Y18.40% ROI- 52W High-0.28% Beta0.77
Dividend %1.04% Quick Ratio- Sales past 5Y-6.10% Gross Margin39.00% 52W Low34.37% ATR0.70
Employees50000 Current Ratio- Sales Q/Q1.60% Oper. Margin-12.00% RSI (14)78.74 Volatility1.23% 1.54%
OptionableYes Debt/Eq- EPS Q/Q31.90% Profit Margin48.90% Rel Volume0.52 Prev Close49.96
ShortableYes LT Debt/Eq- EarningsFeb 01 BMO Payout5.60% Avg Volume3.24M Price50.06
Recom2.80 SMA203.78% SMA507.82% SMA2008.39% Volume1,685,007 Change0.20%
Oct-26-16Reiterated RBC Capital Mkts Sector Perform $50 → $55
Oct-13-16Initiated Wells Fargo Outperform
Jul-27-16Reiterated RBC Capital Mkts Sector Perform $47 → $50
Jun-06-16Resumed JP Morgan Neutral
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $40 → $47
Apr-14-16Upgrade Piper Jaffray Neutral → Overweight
Feb-03-16Reiterated RBC Capital Mkts Sector Perform $37 → $40
Nov-16-15Resumed Piper Jaffray Neutral $90 → $39
Aug-11-15Reiterated Barclays Overweight $43 → $45
Jul-30-15Downgrade Leerink Partners Outperform → Mkt Perform $82 → $40
Jul-13-15Reiterated RBC Capital Mkts Sector Perform $74 → $37
Jul-02-15Reiterated Barclays Overweight $80 → $43
Jul-02-15Downgrade BofA/Merrill Buy → Neutral
Jul-01-15Downgrade Credit Suisse Outperform → Neutral $75 → $39
Jun-24-15Initiated Goldman Buy
May-19-15Reiterated Barclays Overweight $83 → $80
Jan-08-15Reiterated RBC Capital Mkts Sector Perform $72 → $76
Oct-17-14Reiterated RBC Capital Mkts Sector Perform $78 → $72
Oct-17-14Reiterated Barclays Overweight $88 → $83
Jul-18-14Reiterated RBC Capital Mkts Sector Perform $76 → $78
Feb-21-17 08:30AM  Baxter Declares Quarterly Dividend Business Wire
Feb-16-17 08:30AM  Baxter Debuts Enteral Nutrition ENFit® Syringe and Accessory Line During Clinical Nutrition Week 2017 Business Wire
Feb-11-17 12:01AM  [$$] How to Invest With Ackman and Loeb at Barrons.com
Feb-09-17 04:15PM  Baxter to Present at the 38th Annual Raymond James Institutional Investor Conference Business Wire
Feb-08-17 04:15PM  Baxter to Present at the 37th Annual Cowen and Company Healthcare Conference Business Wire
09:10AM  BAXTER INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State
09:00AM  Baxter Appoints Dr. Stephen Oesterle to Its Board Business Wire
Feb-06-17 01:38PM  ETFs with exposure to Baxter International, Inc. : February 6, 2017
09:58AM  Baxter International, Inc. :BAX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
Feb-03-17 03:31PM  Baxter International Inc Bumps Its Bottom Line at Motley Fool
01:40PM  Baxter International, Inc. :BAX-US: Earnings Analysis: 2016 By the Numbers : February 3, 2017
11:55AM  Baxter International, Inc. :BAX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 3, 2017
Feb-02-17 12:45PM  Daniel Loeb's Third Point Hedge Fund 4th Quarter Commentary
Feb-01-17 09:27AM  Baxter International (BAX) Q4 Earnings Beat, Revenues Lag
08:43AM  Baxter International (BAX) Q4 Earnings Beat, Sales Miss
08:30AM  Baxter International Inc Earnings Call scheduled for 8:30 am ET today
07:36AM  Baxter beats 4Q profit forecasts
07:13AM  Baxter Reports 2016 Fourth-Quarter and Full-Year Results Business Wire
07:07AM  Q4 2016 Baxter International Inc Earnings Release - Before Market Open
Jan-30-17 12:00AM  Back to zero: Companies use 1970s budget tool to cut costs as they hunt for growth Reuters
Jan-27-17 09:32AM  Will Baxter International (BAX) Disappoint in Q4 Earnings?
Jan-26-17 12:40PM  Baxter International, Inc. : BAX-US: Dividend Analysis : December 02nd, 2016 (record date) : By the numbers : January 26, 2017
Jan-19-17 04:15PM  Baxter to Present at the 6th Annual Leerink Partners Global Healthcare Conference Business Wire
09:15AM  Baxters Renal Therapy Services Significantly Reduced Peritonitis Infections among Home Dialysis Patients Business Wire
Jan-18-17 10:00AM  Spectrum Health Recognized for Excellence in Community Service with 2016 Foster G. McGaw Prize Business Wire
07:49AM  Baxter (BAX): Sluggish Macro Environment Mars Prospects
Jan-12-17 08:37PM  Baxter to pay $18 mln over mold at North Carolina plant Reuters
06:05PM  Baxter Healthcare to pay $18 mln to resolve liability -U.S. Reuters
09:08AM  How Is Mylans Generics Segment Doing?
Jan-11-17 10:26AM  Baxter International, Inc. Value Analysis (NYSE:BAX) : January 11, 2017
08:15AM  Blog Coverage Teleflex's Arrow(R) VPS Rhythm(TM) Device gets FDA Clearance; Launches Laryngeal Mask Accesswire
Jan-10-17 06:15PM  Bill Nygren Comments on Baxter
12:36PM  Bill Nygren's Oakmark Fund Commentary: Fourth Quarter 2016
07:24AM  Baxter International, Inc. breached its 50 day moving average in a Bullish Manner : BAX-US : January 10, 2017
Jan-09-17 09:00AM  New Data Show U.S. Hospital Readmissions are 54 Percent Higher for Malnourished Patients Business Wire
Jan-06-17 04:15PM  Baxter International Inc. to Host Fourth Quarter 2016 Financial Results Conference Call for Investors Business Wire
Dec-30-16 09:34AM  Is Baxter Poised to Counter Low Cyclophosphamide Sales?
Dec-27-16 07:49AM  Boston Scientific Down on Risks; Innovations Raise Hope
Dec-26-16 07:36AM  Financial Metrics of Baxters Acquisition of Claris Injectables
Dec-23-16 12:35PM  How Baxters Acquisition of Claris Injectables Could Boost Growth
11:05AM  Baxter Advances Portfolio with Acquisition of Claris Injectables
09:21AM  What Do Analysts Recommend for Baxter International?
07:32AM  Myriad Genetics: United Rheumatology Selects Vectra DA Test
Dec-22-16 07:59AM  Henry Schein Named 2016's Best Animal Healthcare Provider
Dec-21-16 03:52PM  Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys at Motley Fool
08:35AM  VWR Plagued by Headwinds, Solid Fundamentals Raise Hope
07:49AM  Chemed (CHE): Roto-Rooter Solid, Reimbursement a Concern
Dec-20-16 08:24AM  CVS Health (CVS) Down on Prevailing Risks, Tepid Guidance
07:47AM  Zimmer Biomet (ZBH): Spine Group Solid, Q3 Results a Drag
07:34AM  Align Technology Hits 52-Week High on Q3 & Dental Strength
Dec-19-16 11:40AM  BloodCenter, Versiti name ex-Eli Lilly exec to succeed Jackie Frederick as CEO at bizjournals.com
08:42AM  Bruker (BRKR) Buys Active Spectrum to Boost MRI Business
08:30AM  Hill Rom Gains on Solid Q4, Buyouts & Product Launches
Dec-16-16 01:53PM  [$$] Baxter's $650 Million Buy Is a Booster Shot at Barrons.com
08:35AM  CVS Health Revises View for 2016 & 2017, Declares Dividend
07:22AM  Baxter (BAX) to Acquire India-Based Claris Injectables
Dec-15-16 09:51AM  Baxter Acquires Claris Injectables Unit for $625 Million
09:01AM  Hologic Hits 52-Week High on Q4 Earnings & Solid Prospects
08:10AM  Baxter to Expand Portfolio of Essential Generic Injectable Medicines with Acquisition of Claris Injectables Limited Business Wire
Dec-14-16 08:38AM  Zimmer Biomet (ZBH) Launches PrimaGen Advanced Allograft
08:24AM  Boston Scientific Acquires Neovasc to Boost Heart Business
Dec-13-16 08:44AM  Inovalon (INOV) Cuts 2016 Revenue and Earnings Guidance
07:28AM  Align Up on Balanced Growth, Expansion of Invisalign Teen
Dec-12-16 09:30AM  Zacks.com featured highlights: Baxter International, MAM Software Group, Advanced Energy Industries, Apricus Biosciences and Copart
07:52AM  Amedisys Down on Dismal Quarter, Reimbursement Headwind
Dec-09-16 09:44AM  5 Efficient Stocks to Buy for Superlative Returns
Dec-08-16 09:11AM  Henry Schein's Q3 Results Impress, Pricing Pressure a Drag
09:00AM  Baxter Announces Winners of Seventh Annual LEAP Award Recognizing Hospital Pharmacies for Excellence in Lean Practices and Safety Initiatives Business Wire
Dec-07-16 04:15PM  Baxter to Present at the 35th Annual J.P. Morgan Healthcare Conference Business Wire
08:16AM  Genomic Health: Cancer Test Business Strong, Q3 Dismal
Dec-06-16 07:58AM  Omnicell Unveils XT Series Automated Dispensing System
Dec-05-16 10:28AM  5 Healthcare Stocks Billionaires Are Buying at Insider Monkey
09:00AM  Baxter Receives Perfect Score from Human Rights Campaign Foundation Business Wire
08:30AM  Baxter Introduces New Safety Management System and Software Updates for Sigma Spectrum Infusion System at ASHP Meeting Business Wire
08:10AM  Boston Scientific (BSX) Inks $75 Million Deal with Neovasc
Dec-02-16 07:29AM  Medtronic Stock Falls on Mixed 2Q; Positive on HeartWare Buy
Dec-01-16 12:20PM  Is Baxter International Inc. (BAX) A Good Stock To Buy? at Insider Monkey
11:05AM  Baxters Latest Dividend and Share Repurchase Authorization
10:05AM  Baxter Makes Significant Advancements in Hemodialysis Treatments
08:24AM  Medtronic Partners UH to Launch Integrated Health Solutions
08:05AM  How Baxter Continues to Contribute to Patient Care
Nov-30-16 06:04PM  Discussing Baxter Internationals Recent Stock Performance
04:02PM  Analysts Latest Recommendations for Baxter: Mostly Holds
07:39AM  Baxter (BAX) Inks Partnership with Americares, Stock Down
Nov-29-16 11:00AM  Americares and Baxter International Foundation Announce Oral Health Project to Prevent Systemic Health Issues in Low-Income Patients Business Wire
09:14AM  NuVasive: Q3 Results Lack Shine, Spine Market Holds Promise
09:03AM  Edward Lifesciences (EW) to Buy Israel's Valtech Cardio
Nov-28-16 07:58AM  Walgreen Boots: Mixed Q4, Awaits Rite Aid Deal Closure
07:38AM  Haemonetics (HAE) Hits a 52-Week High on Solid Prospects
Nov-25-16 08:40AM  STERIS (STE): Q2 Results Disappoint, Acquisitions Bode Well
Nov-24-16 01:22PM  Hedge Funds Are Crazy About Southwest Airlines Co. (LUV) at Insider Monkey
Nov-23-16 05:47AM  IDEXX: Strength in International Business & CAG Continues
Nov-22-16 10:06AM  Medtronic (MDT) Tops Q2 Earnings, Lowers FY17 Guidance
08:19AM  Haemonetics: Medical Center of Plano Picks BloodTrack
08:01AM  Baxter: ASN Marks SHARESOURCE & AMIA APD Efficient
08:00AM  Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy Business Wire
Nov-21-16 09:09AM  Medtronic's (MDT) Heli-FX EndoAnchor System Data Positive
09:00AM  New Data Presented at ASN Kidney Week Spotlight Baxters SHARESOURCE Telehealth Platform and AMIA APD System in Supporting More Efficient Home Dialysis Care Business Wire
07:35AM  Bruker Buys OST, To Expand in Superconducting Wires Market
Nov-18-16 06:04AM  CVS Health (CVS): Sluggish Q3, Guidance Cut Pose Concerns
Baxter International Inc. provides a portfolio of renal and hospital products. Its Renal segment provides products and services to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis (HD), home HD, continuous renal replacement therapy, and additional dialysis services. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. Baxter International Inc. offers its products through direct sales force, independent distributors or sales agents, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. The company was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FORSYTH JOHN DDirectorFeb 08Option Exercise30.734,280131,52431,338Feb 10 04:02 PM
FORSYTH JOHN DDirectorFeb 08Sale48.354,280206,93827,058Feb 10 04:02 PM
Shapazian Carole JDirectorFeb 06Option Exercise30.734,280131,52413,507Feb 08 04:14 PM
Shapazian Carole JDirectorFeb 06Sale48.234,280206,4249,227Feb 08 04:14 PM
STORM KORNELIS J.DirectorNov 18Option Exercise30.734,280131,52425,208Nov 22 04:27 PM
STORM KORNELIS J.DirectorNov 18Sale47.104,280201,58820,928Nov 22 04:27 PM
ALMEIDA JOSE EChairman of the Board and CEOMay 23Buy42.7511,691499,79011,691May 24 07:39 AM
FORSYTH JOHN DDirectorMay 02Option Exercise20.961,88739,55226,320May 04 05:46 PM
FORSYTH JOHN DDirectorMay 02Sale44.381,88783,74524,433May 04 05:46 PM
FORSYTH JOHN DDirectorApr 04Option Exercise20.961,88739,55226,315Apr 06 05:35 PM
FORSYTH JOHN DDirectorApr 04Sale41.751,88778,78224,428Apr 06 05:35 PM
GAVIN JAMES R IIIDirectorMar 14Option Exercise20.965,660118,63433,432Mar 15 04:30 PM
STROUCKEN ALBERT P LDirectorMar 14Sale40.335,660228,26818,759Mar 15 04:31 PM
GAVIN JAMES R IIIDirectorMar 14Sale40.345,660228,32427,772Mar 15 04:30 PM